A Pilot Study of Pivanex in Patients With Chronic Lymphocytic Leukemia
NCT00083473
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
28
Enrollment
INDUSTRY
Sponsor class
Conditions
Leukemia, Lymphocytic, Chronic
Lymphoma, Small Lymphocytic
Interventions
DRUG:
Pivanex
Sponsor
Titan Pharmaceuticals